Business News • PR NewsWire • Alder Biopharmaceuticals Announces That Data From Multiple Studies of ALD518 (BMS945429), an Investigational Antibody Therapeutic in Rheumatoid Arthritis Patients, to be Presented at Annual Meeting of the American College of Rheumatology

Alder Biopharmaceuticals Announces That Data From Multiple Studies of ALD518 (BMS945429), an Investigational Antibody Therapeutic in Rheumatoid Arthritis Patients, to be Presented at Annual Meeting of the American College of Rheumatology

Alder Biopharmaceuticals Announces That Data From Multiple Studies of ALD518 (BMS945429), an Investigational Antibody Therapeutic in Rheumatoid Arthritis Patients, to be Presented at Annual Meeting of the American College of Rheumatology

ATLANTA, Nov. 6, 2010 /PRNewswire/ -- Alder Biopharmaceuticals Inc. today announced that data from two clinical studies of its ALD518 investigational antibody therapeutic will be presented at the Annual Meeting of the American College of Rheumatology in Atlanta. "We continue to be encouraged about t

View More : http://www.prnewswire.com/news-releases/alder-biopharmaceuticals-announces-that-data-from-multiple-studies-of-ald518-bms...

Releted News by prnewswire

VIDEO From Mazda North America Available on thenewsmarket.com: Mazda to Unveil All-New 2012 Mazda5 and Mazda Shinari Concept at 2010 Los Angeles Auto Show

DVDFab Now Supports the Newest Avatar 3D BD+